Tagamet and Enterococcal infection - a phase IV clinical study of FDA data

Summary:

Enterococcal infection is reported as a side effect among people who take Tagamet (cimetidine), especially for people who are female, 50-59 old, also take Rocephin, and have Systemic lupus erythematosus.

The phase IV clinical study analyzes which people have Enterococcal infection when taking Tagamet. It is created by eHealthMe based on reports of 8,789 people who have side effects when taking Tagamet from the FDA, and is updated regularly.

What is Tagamet?

Tagamet has active ingredients of cimetidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 9,011 Tagamet users. Check the latest studies of Tagamet.

What is Enterococcal infection?

Enterococcal infection is found to be associated with 629 drugs and 760 conditions by eHealthMe. Check the latest studies of Enterococcal infection.

On Jul, 14, 2026

8,789 people reported to have side effects when taking Tagamet.
Among them, 33 people (0.38%) have Enterococcal infection.

Could Tagamet cause Enterococcal infection?

Among these 33 people:

What is the gender of people who have Enterococcal infection when taking Tagamet? *

female: 93.94 %
male: 6.06 %

What is the age of people who have Enterococcal infection when taking Tagamet? *

What are other drugs people take besides Tagamet? *

What are other side effects people have besides Enterococcal infection? *

Acute Kidney Failure: 30 people, 90.91%
Osteoporosis (bones weak and more likely to break): 30 people, 90.91%
Bone Disorder: 29 people, 87.88%
Osteopenia (a condition where bone mineral density is lower than normal): 29 people, 87.88%
Stomatitis (inflammation of mucous membrane of mouth): 29 people, 87.88%
Sepsis (a severe blood infection that can lead to organ failure and death): 29 people, 87.88%
Pleural Effusion (water on the lungs): 29 people, 87.88%
Cellulitis (infection under the skin): 29 people, 87.88%
Pain: 29 people, 87.88%
Osteomyelitis (infection of bone): 29 people, 87.88%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 27 people, 81.82%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 27 people, 81.82%
Thrombocytopenia (decrease of platelets in blood): 11 people, 33.33%
Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle): 1 person, 3.03%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 3.03%
Bladder Disorder: 1 person, 3.03%
Blood Pressure Abnormal: 1 person, 3.03%
Bone Disorder: 1 person, 3.03%
Depression: 1 person, 3.03%
Metastases To Bone (cancer spreads to bone): 1 person, 3.03%

* Approximation only. Some reports may have incomplete information.

Do you take Tagamet and have Enterococcal infection?

- Check whether Enterococcal infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tagamet:

Tagamet (9,011 reports)

Browse all side effects of Tagamet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Enterococcal infection:

Enterococcal infection (629 drugs)

Browse all the conditions that are associated with Enterococcal infection:

Enterococcal infection (760 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cimetidine (the active ingredients of Tagamet) and Tagamet (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.